To investigate the specific cell death pathways activated by compound 12, we conducted Western blot analyses focused on the expression levels of caspase-3, caspase-8, and caspase-1 in HCT-116 colorectal carcinoma cells. This evidence concerns the gene CASP3 and colorectal carcinoma.